ContractUnderwriting Agreement • January 20th, 2005 • Albemarle Corp • Plastic materials, synth resins & nonvulcan elastomers • New York
Contract Type FiledJanuary 20th, 2005 Company Industry JurisdictionAlbemarle Corporation, a corporation organized and existing under the laws of the Commonwealth of Virginia (the “Company”), proposes, subject to the terms and conditions stated herein, to issue and sell to the several underwriters named in Schedule I hereto (the “Underwriters”) $325,000,000 in aggregate principal amount of its 5.10% Senior Notes due 2015 (the “Notes”). The Notes are to be issued pursuant to an Indenture, dated as of January 20, 2005, between the Company and The Bank of New York, as Trustee (the “Trustee”), as supplemented by the First Supplemental Indenture, dated of January 20, 2005 (as supplemented, the “Indenture”). Banc of America Securities LLC, UBS Securities LLC and Bear, Stearns & Co. Inc. are acting as representatives (together, the “Representatives”), in connection with the offering and sale of the Notes contemplated herein (the “Offering”).
Senior Notes due 2014 ALBEMARLE CORPORATION UNDERWRITING AGREEMENTUnderwriting Agreement • December 10th, 2004 • Albemarle Corp • Plastic materials, synth resins & nonvulcan elastomers • New York
Contract Type FiledDecember 10th, 2004 Company Industry JurisdictionAlbemarle Corporation, a corporation organized and existing under the laws of the Commonwealth of Virginia (the “Company”), proposes, subject to the terms and conditions stated herein, to issue and sell to the several underwriters named in Schedule I hereto (the “Underwriters”) $ in aggregate principal amount of its % Senior Notes due 2014 (the “Notes”). The Notes are to be issued pursuant to an Indenture, dated as of , 2004, between the Company and The Bank of New York, as Trustee (the “Trustee”), as supplemented by the First Supplemental Indenture, dated of , 2004 (as supplemented, the “Indenture”). Banc of America Securities LLC, UBS Securities LLC and Bear, Stearns & Co. Inc. are acting as representatives (together, the “Representatives”), in connection with the offering and sale of the Notes contemplated herein (the “Offering”).
ALARIS Medical, Inc. 7¼% Senior Subordinated Notes due 2011 UNDERWRITING AGREEMENT June 25, 2003Underwriting Agreement • July 14th, 2003 • Alaris Medical Systems Inc • Surgical & medical instruments & apparatus • New York
Contract Type FiledJuly 14th, 2003 Company Industry JurisdictionALARIS Medical, Inc., a corporation organized and existing under the laws of Delaware (the “Company”), proposes, subject to the terms and conditions stated herein, to issue and sell to the several underwriters named in Schedule I hereto (the “Underwriters”) an aggregate of $175,000,000 principal amount of the Company’s 7¼% Senior Subordinated Notes due 2011 (the “Notes”). The Notes will be issued pursuant to the indenture dated as of June 30, as supplemented by the first supplemental indenture (as so supplemented, the “Indenture”), dated as of the Closing Date (as defined below), between the Company and The Bank of New York, as trustee. Bear, Stearns & Co. Inc., Citigroup Global Markets Inc., UBS Securities LLC, CIBC World Markets Corp. and Jefferies & Company, Inc. (the “Representatives”) are acting as co-managers in connection with the offering and sale of the Notes (the “Offering”).